These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Coronary risk reduction in office practice. Luikart WM J La State Med Soc; 1974 Feb; 126(2):51-7. PubMed ID: 4815661 [No Abstract] [Full Text] [Related]
10. Hypertension: a new perspective in therapy and metabolic effect. Part I. Medina Ruiz A Bol Asoc Med P R; 1991 Sep; 83(9):399-401. PubMed ID: 1807274 [TBL] [Abstract][Full Text] [Related]
11. [Management of lipid disorders in diabetes]. Okubo M; Murase T Nihon Rinsho; 1997 Nov; 55 Suppl():776-80. PubMed ID: 9434563 [No Abstract] [Full Text] [Related]
12. Importance of hyperlipidaemia and therapy in renal patients. Wanner C Nephrol Dial Transplant; 2000; 15 Suppl 5():92-6. PubMed ID: 11073280 [No Abstract] [Full Text] [Related]
13. [Insulin resistance and hyperinsulinemia--clinical aspects]. Kozek E Przegl Lek; 1996; 53(9):647-52. PubMed ID: 8992530 [TBL] [Abstract][Full Text] [Related]
14. [Significance of setting standards and guidelines for management of patients with hyperlipidemia]. Kotake H; Oikawa S Nihon Rinsho; 2001 Mar; 59 Suppl 3():492-9. PubMed ID: 11347119 [No Abstract] [Full Text] [Related]
15. Prevention of coronary heart disease: a nonhormonal approach. Lewis V; Hoeger K Semin Reprod Med; 2005 May; 23(2):157-66. PubMed ID: 15852201 [TBL] [Abstract][Full Text] [Related]
16. Guidelines for the detection of high-risk lipoprotein profiles and the treatment of dyslipoproteinemias. Canadian Lipoprotein Conference Ad Hoc Committee on Guidelines for Dyslipoproteinemias. CMAJ; 1990 Jun; 142(12):1371-82. PubMed ID: 2190685 [TBL] [Abstract][Full Text] [Related]